Riskpilot← Back to searchSign inGet full accessKYSTVEIEN LEGESENTER DA
DAActiveOrg 974634341Kystveien 244, 4841 ArendalGeneral medical practice activities · NACE 8621Est. 20135 employees
Revenue 2024
NOK 4,9M
+14% vs 2023
EBITDA margin
6.5%
+55% vs 2023
Equity ratio
50.1%
Financial strength
Net profit 2024
NOK 302K
+75% vs 2023
| Revenue | NOK 4,9M | +14% |
| EBITDA | NOK 321K | +55% |
| Net profit | NOK 302K | +75% |
| Total assets | NOK 862K | +5% |
| Equity | NOK 432K | +234% |
| Employees | 5 | — |
Legal name
KYSTVEIEN LEGESENTER DA
Org number
974634341
Legal form
Ansvarlig Selskap Med Delt Ansvar
NACE code
8621 · General medical practice activities
Founded
23. november 2013
Share capital
—
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Administrativt drift av legekontor, herunder anskaffelse av utstyr, dataprogrammer etc. Som brukes i fellesskap.
Address
Kystveien 244, 4841 Arendal
Phone
+4737030522
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 970 | 3 224 | 3 568 | 4 331 | 4 928 |
| Staff expenses | −1 437 | −1 504 | −1 666 | −2 062 | −2 447 |
| EBITDA | 47 | 73 | −172 | 207 | 321 |
| Depreciation & amort. | −57 | −60 | −43 | −34 | −28 |
| EBIT | −10 | 13 | −215 | 173 | 294 |
| Net financials | 0 | −0 | 1 | 0 | 9 |
| Profit before tax | −10 | 13 | −214 | 173 | 302 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −10 | 13 | −214 | 173 | 302 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 456 | 514 | 317 | 824 | 862 |
| Equity | 158 | 171 | −44 | 129 | 432 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 298 | 343 | 361 | 694 | 431 |
| Total debt | 298 | 343 | 361 | 694 | 431 |
EBITDA margin
6.5%
This company
15.8%
Market median
-59% vs market
20202024
Equity ratio
50.1%
This company
38.2%
Market median
+31% vs market
20202024
Return on equity
70.0%
This company
18.4%
Market median
+280% vs market
20202024
Net profit margin
6.1%
This company
8.1%
Market median
-25% vs market
20202024
Asset turnover
5.71×
This company
1.12×
Market median
+410% vs market
20202024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 0% | 0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KYSTVEIEN LEGESENTER DA also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjetil Tørå Dokka | Board of Directors | 0 companies |
| Birgit Wigeland Moy | Board of Directors | 0 companies |
| Magnus Kåre Skjeggedal Andersen | Board of Directors | 0 companies |
| Erik Lønnmark Werner | Chairman | 0 companies |
| Cecilie Mortensen | Board of Directors | 0 companies |